A small developer of predictive analytical software tools for stock traders recently signed a $5 million international licensing agreement for its technology. The deal gives its licensing partner exclusive marketing […]
For many startups, going all the way from IP development to market launch is often capital intensive. Many times funding is hard to get because of the high costs and risks involved. That’s where the licensing route is one of best strategies to use.
R&D is an expensive undertaking…especially for certain industries such as bio-sciences or pharmaceuticals. But sometimes your know-how, such as an R&D process, can turn into a licensable (and valuable) intellectual property that others can use to develop their IP.
One example is a small pharmaceutical company, who licenses its antibody R&D platform to other drug companies. In return for rights to use the R&D platform, licensees pay fees to use it and royalties on sales from each product incorporating its antibody technology.
Your business carries insurance for its products, worker comp, property and executive liability. But what about its most valuable asset-intellectual property? It isn’t covered under your general business liability policy.
For most businesses today, IP is critical – its the core asset for current and future revenues and shareholder value. Getting caught in an infringement litigation case can be a financial disaster. Especially if you’re a small business or startup.
Fortunately, there is a way to way to manage the costs of IP litigation without breaking the bank. It’s called Intellectual Property Insurance.
Most investors invest with little or no knowledge about the company’s intellectual property. Two big reasons why is they don’t understand IP, and they don’t know the value of IP […]